华润江中药业股份有限公司关于第二期限制性股票激励计划预留授予结果公告

Core Viewpoint - The announcement details the completion of the second phase of the restricted stock incentive plan by China Resources Jiangzhong Pharmaceutical Co., Ltd, including the allocation of 660,000 shares to 28 eligible participants at a price of 13.70 yuan per share [2][5]. Group 1: Incentive Plan Details - The board approved the grant of 660,000 restricted shares on February 3, 2026, with a grant price of 13.70 yuan per share [2][5]. - The registration date for the restricted shares is February 12, 2026, and the total number of shares registered is 660,000 [4][11]. - The incentive plan has a maximum validity period of 120 months from the completion of the registration [6]. Group 2: Vesting and Lock-up Period - The lock-up period for the granted shares is set at 24, 36, and 48 months, during which the shares cannot be transferred or used as collateral [6]. - The conditions for lifting the lock-up include the company not having any adverse audit opinions and the participants not being disqualified by regulatory authorities [7][8]. Group 3: Financial Impact and Use of Funds - The total subscription amount received from the participants is 9,042,000 yuan, which will be used to supplement the company's operating funds [13]. - The issuance of the restricted shares will increase the company's total share capital by 660,000 shares, slightly diluting the controlling shareholder's stake from 43.14% to 43.09% [12]. Group 4: Accounting and Valuation - The fair value of the restricted shares will be determined based on the closing price on the grant date, and the cost of share-based payments will be recognized accordingly [14]. - The estimated impact on the company's financial status and operating results will be assessed in future accounting reports [15].